EmpiRx Health Lowers Drug Spend In Mental Health

In an interview with Formulary Watch, EmpiRx Health CEO Karthik Ganesh discusses how the PBM was able to decrease mental health drug spending at a time when utilization is increasing.

Despite an increase in utilization of medications to treat mental health disorders between 2020 and 2021, EmpiRx Health’s drug spend for commercial payers actually decreased. Overall, behavioral health categories drove an increase of 9.4% in pharmacy claims year-over-year. EmpiRx Health saw a decrease of 4.7% in plan paid per utilizer.

The decrease, EmpiRx Health CEO Karthik Ganesh told Formulary Watch in an interview, is a result of the PBM’s value-based approach to healthcare.

Read more

Share:

Share on linkedin

More Posts

Environmental, Social, and Governance (ESG) Policy

EmpiRx Health believes that Environmental, Social, and Governance (ESG) principles are crucial to developing a resilient healthcare services company whose workforce diversity resembles the clients and patients we serve. These principles are integrated into our operating discipline, reflected in our social and workplace priorities, good corporate governance, and environmental management, and backed by data-driven monitoring and reporting that hold us accountable for successful outcomes.

Read More

Contact Us

Ready to learn about a different way to approach your pharmacy benefits? 

Request our client success case studies.

Fill in your details to receive the EmpiRx Health case studies.

  • This field is for validation purposes and should be left unchanged.